MeCP2 is a transcriptional activator/repressor which is thought to be involved in pleiotropic activities, but exactly how the spectrum of MeCP-2 mutations leads to RTT phenotypes is unclear and unfortunately, to date, no cure for the disease exists1,2. The gene discussed is MECP2; the disease is Rett syndrome.